Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amrutanjan Health CareBOM:590006 -0.70%71 Days Payable is 120.04 as of Jun. 2026, which is 22% above its 10-year median of 98.59. GuruFocus rates BOM:590006 with a GF Score™ of 71/100 and a GF Value™ of ₹827.69 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 928 Drug Manufacturers companies, Amrutanjan Health Care ranks better than 54.53% on this metric.
The historical rank and industry rank for Amrutanjan Health Care's Days Payable or its related term are showing as below:
BOM:590006'
s Days Payable Range Over the Past 10 Years
Min: 86.44 Med: 98.59 Max: 108.19
Current: 96.87
During the past 13 years, Amrutanjan Health Care's highest Days Payable was 108.19. The lowest was 86.44. And the median was 98.59.
BOM:590006's Days Payable is ranked better than 54.53% of 928
companies
in the Drug Manufacturers industry
Industry Median: 88.385
vs BOM:590006: 96.87
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Amrutanjan Health Care's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amrutanjan Health Care Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amrutanjan Health Care's Days Payable distribution charts can be found below:
* The bar in red indicates where Amrutanjan Health Care's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Amrutanjan Health Care's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amrutanjan Health Care (BOM:590006) has a Days Payable of 120.04 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Amrutanjan Health Care and its competitors. This is 22% above median its historical median of 98.59. Over the past decade, Amrutanjan Health Care's Days Payable has ranged from 86.44 to 108.19. According to the industry distribution chart, Amrutanjan Health Care ranks #422 out of 928 companies in the Drug Manufacturers industry, placing it in the top 45.5%.
Is Amrutanjan Health Care's Days Payable too high?
Amrutanjan Health Care's current Days Payable of 120.04 is 22% above median its 10-year median of 98.59. Over the past 10 years, this metric has ranged from a low of 86.44 to a high of 108.19. The Drug Manufacturers industry median Days Payable is 88.39. Amrutanjan Health Care's value of 120.04 is 35.8% above this industry median. Based on the distribution chart, Amrutanjan Health Care ranks #422 out of 928 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Amrutanjan Health Care has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Amrutanjan Health Care's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Amrutanjan Health Care ranks #422 out of 928 companies for Days Payable. This puts Amrutanjan Health Care in the upper half of its industry. The industry median Days Payable is 88.39. Amrutanjan Health Care's value of 120.04 is 35.8% above this benchmark. Historically, Amrutanjan Health Care's own Days Payable has ranged from 86.44 to 108.19 over the past decade. While the company's 10-year median is 98.59 vs. the industry median of 88.39, Amrutanjan Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.39, based on 928 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amrutanjan Health Care's current Days Payable of 120.04 is 35.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Amrutanjan Health Care and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amrutanjan Health Care's current Days Payable is 120.04, which is 22% above median its own 10-year median of 98.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amrutanjan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Amrutanjan Health Care (BOM:590006) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹827.69, compared to a current price of ₹490.35 — trading 40.8% below its estimated fair value. The current Days Payable is 120.04, which is 22% above median its 10-year median of 98.59 and 35.8% above the Drug Manufacturers industry median of 88.39. Amrutanjan Health Care's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Amrutanjan Health Care (BOM:590006), the current Days Payable is 120.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amrutanjan Health Care (BOM:590006) Overvalued in 2026?
Based on GuruFocus' analysis, Amrutanjan Health Care stock appears to be undervalued.
The current stock price of ₹490.35 is trading 40.8% below its estimated GF Value™ of ₹827.69.
GuruFocus considers Amrutanjan Health Care to be Significantly Undervalued.
Key valuation signals for BOM:590006:
Days Payable: 120.04 (22% above median its 10-year median of 98.59)
GF Value™: ₹827.69 vs. price of ₹490.35 (40.8% below fair value)
Industry Position: 35.8% above the Drug Manufacturers median (#422 of 928)
No single metric tells the full story. See the BOM:590006 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkins, and inhalers. Geographically, it generates the majority of the revenue from India.
71GF Score
Get the complete analysis for BOM:590006
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:590006 has been successfully added to your 
